Leerink Partners Strengthens M&A Team with Notable Hirings
People | Nov 14, 2024 | Leerink Partners LLC
Leerink Partners, a premier investment bank focusing on healthcare, has enhanced its M&A team by hiring Grant Curry and Jason Truman as Senior Managing Directors. The move comes as Leerink celebrates a year since its management-led buyout, indicating strong expected top-line growth in 2024. Both Curry and Truman bring robust backgrounds in biopharma M&A, bolstering Leerink’s ability to offer comprehensive advisory services. This strategic expansion aligns with Leerink’s plan to capitalize on its sector leadership in biopharma capital markets and broad client base. Grant Curry, previously at Gordon Dyal & Co., and Jason Truman from Guggenheim Securities, collectively bring over two decades of experience and have collectively advised on M&A transactions worth over $230 billion.
Sectors
- Investment Banking
- Biopharma
- Healthcare
Geography
- United States – Leerink Partners is a US-based investment bank and the article pertains to its operations and expansions within the country.
- Europe – Grant Curry has experience advising European clients, indicating a geographical impact extending beyond the US.
Industry
- Investment Banking – The article discusses Leerink Partners, an investment bank specializing in healthcare, and its expansion in the M&A sector.
- Biopharma – The hiring focuses on strengthening the biopharma M&A team, indicating relevance to the biopharma industry.
- Healthcare – Leerink Partners specializes in healthcare financial advisory, making this industry relevant to the firm's activities.
Financials
- $230 billion – Collective M&A transaction value advised by Grant Curry and Jason Truman over the past decade.
- $65 billion – Total advisory deal value by Leerink Partners since its inception.
- $170 billion – Total capital raised by Leerink Partners for its clients.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Leerink Partners | Investment Bank | Company | A healthcare-focused investment bank enhancing its M&A capabilities. |
| Grant Curry | Senior Managing Director | Person | New hire with extensive experience in biopharma M&A and activism defense. |
| Jason Truman | Senior Managing Director | Person | New hire with a strong background in investment banking and biopharma M&A. |
| Guggenheim Securities | Previous Employer | Company | Jason Truman's former employer, where he played a critical role in biopharma M&A. |
| Gordon Dyal & Co. | Previous Employer | Company | Grant Curry's former employer, where he advised on high-profile biopharma transactions. |
| Credit Suisse | Former Employer | Company | Jason Truman previously worked here, specializing in biopharma M&A. |
| Morgan Stanley | Former Employer | Company | Jason Truman previously worked here in biopharma M&A. |
| UBS | Former Employer | Company | Previously employed Grant Curry as part of their Global Healthcare Group. |